Physicians identified key improvements for adrenaline auto-injectors, including longer shelf life and easier use, improving anaphylaxis care. Learn more.

Aspire Allergy & Sinus Dr. Haley Overstreet highlights new research on needle-free treatment for severe allergic reactions. Epinephrine saves lives—but too often, hesitation gets in the way. A ...

The US Food and Drug Administration approved the first nasal spray epinephrine drug for severe allergic reactions known as anaphylaxis, providing a needle-free alternative to EpiPens and similar ...

Epinephrine now available in a nasal spray formulation (neffy) is being hailed as a way to diminish barriers to use, which is critical in emergency situations such as an anaphylactic reaction. The ...

ALK presents new findings that directly compare user preference between needle-free nasal and injectable adrenaline treatments for anaphylaxis, demonstrating that 88% of participants prefer EURneffy-t ...

THURSDAY, Oct. 2, 2025 (HealthDay News) — People with extreme, life-threatening allergic reactions might do as well to use a nasal spray as jab themselves in a thigh with an EpiPen, a new evidence ...

The plans, due to come into force in September, follow support for Benedict's Law, a campaign to improve allergy safety in schools.

While there’s no cure for food allergies, some medications like antihistamines, adrenaline, and omalizumab can help manage symptoms and prevent serious reactions. There’s no cure for food allergies.

Please provide your email address to receive an email when new articles are posted on . Fears of pain or misuse may cause delays in autoinjector use during anaphylaxis. Patients experienced higher ...

34-member international panel led by experts at Cincinnati Children's offers first consensus guidelines that seek to improve self-care and reduce unnecessary emergency visits CINCINNATI, Dec. 10, 2025 ...

The UK government will require schools to provide adrenaline pens, staff allergy training, and updated health policies from ...

ALK presents new findings that directly compare user preference between needle-free nasal and injectable adrenaline treatments for anaphylaxis, demonstrating that 88% of participants prefer ...